Skip to main content

ADVERTISEMENT

Edan Stanley

Conference Coverage
12/15/2021
“When offered information about clinical trials, the majority of patients agreed to a Leukemia & Lymphoma Society’s Clinical Trial Support Center referral, suggesting that patients are generally willing to receive education and information...
“When offered information about clinical trials, the majority of patients agreed to a Leukemia & Lymphoma Society’s Clinical Trial Support Center referral, suggesting that patients are generally willing to receive education and information...
“When offered information about...
12/15/2021
Veterans Health Today
Conference Coverage
12/15/2021
Researchers of a study presented at the 63rd ASH Annual Meeting & Exposition explained how management of cancer-associated thrombosis remains complex and offer insight from their pilot program seeking to improve clinic and expert access to...
Researchers of a study presented at the 63rd ASH Annual Meeting & Exposition explained how management of cancer-associated thrombosis remains complex and offer insight from their pilot program seeking to improve clinic and expert access to...
Researchers of a study presented...
12/15/2021
Veterans Health Today
Conference Coverage
12/14/2021
Initial real-world data offers encouraging results on the efficacy and tolerability of isatuximab with pomalidomide and dexamethasone for patients with relapsed/refractory multiple myeloma, according to a poster presentation at the 63rd ASH...
Initial real-world data offers encouraging results on the efficacy and tolerability of isatuximab with pomalidomide and dexamethasone for patients with relapsed/refractory multiple myeloma, according to a poster presentation at the 63rd ASH...
Initial real-world data offers...
12/14/2021
First Report Managed Care
Conference Coverage
12/14/2021
According to data presented at the 63rd ASH Annual Meeting & Exposition, updated patient-reported outcomes show sustained and clinically meaningful improvements for patients with multiple myeloma treated with daratumumab.
According to data presented at the 63rd ASH Annual Meeting & Exposition, updated patient-reported outcomes show sustained and clinically meaningful improvements for patients with multiple myeloma treated with daratumumab.
According to data presented at...
12/14/2021
First Report Managed Care
News
11/22/2021
The US Department of Health and Human Services recently published a report exploring the costs associated with surprise medical billing and highlighted how the No Surprises Act will change practices in 2022.
The US Department of Health and Human Services recently published a report exploring the costs associated with surprise medical billing and highlighted how the No Surprises Act will change practices in 2022.
The US Department of Health and...
11/22/2021
First Report Managed Care
Podcast
10/29/2021
Karen Ferguson, MS, former practice administrator, consultant, and cofounder and CEO of Discus Analytics, Inc, discusses the role value-based care models have to play in transforming rheumatology care, including their effects on costs,...
Karen Ferguson, MS, former practice administrator, consultant, and cofounder and CEO of Discus Analytics, Inc, discusses the role value-based care models have to play in transforming rheumatology care, including their effects on costs,...
Karen Ferguson, MS, former...
10/29/2021
First Report Managed Care
Conference Coverage
10/28/2021
Austin Lee Chiang, MD MPH, assistant professor of medicine, Div. Gastroenterology & Hepatology, director, Endoscopic Bariatric Program, Thomas Jefferson University Hospital, chief medical social media officer, Jefferson Health, founding...
Austin Lee Chiang, MD MPH, assistant professor of medicine, Div. Gastroenterology & Hepatology, director, Endoscopic Bariatric Program, Thomas Jefferson University Hospital, chief medical social media officer, Jefferson Health, founding...
Austin Lee Chiang, MD MPH,...
10/28/2021
First Report Managed Care
Conference Coverage
10/28/2021
Brian Nyquist, president and CEO, National Infusion Center Association, spoke with attendees at NORM 2021 on the importance of driving positive change through patient advocacy and the challenges associated with specialty pharmacy mandates.
Brian Nyquist, president and CEO, National Infusion Center Association, spoke with attendees at NORM 2021 on the importance of driving positive change through patient advocacy and the challenges associated with specialty pharmacy mandates.
Brian Nyquist, president and...
10/28/2021
First Report Managed Care
Andrea Zlatkus, CMPM, CRMS, CRHC, executive director, National Organization of Rheumatology Management (NORM)
Conference Coverage
10/27/2021
Andrea Zlatkus, CMPM, CRMS, CRHC, executive director, National Organization of Rheumatology Management (NORM), offers insight into the unique challenges high deductible health plans present for rheumatology patients and shares what she wished...
Andrea Zlatkus, CMPM, CRMS, CRHC, executive director, National Organization of Rheumatology Management (NORM), offers insight into the unique challenges high deductible health plans present for rheumatology patients and shares what she wished...
Andrea Zlatkus, CMPM, CRMS,...
10/27/2021
First Report Managed Care
Conference Coverage
10/20/2021
Biosimilar uptake and adoption had a slow start in the United States, but researchers at AMCP Nexus 2021 shared new research about how the landscape is rapidly growing and shared how payers are responding the evolving market and regulatory...
Biosimilar uptake and adoption had a slow start in the United States, but researchers at AMCP Nexus 2021 shared new research about how the landscape is rapidly growing and shared how payers are responding the evolving market and regulatory...
Biosimilar uptake and adoption...
10/20/2021
First Report Managed Care